English | Español

Community
+ Community
Patient Daily | May 19, 2026

Dr. Oz on declining U.S. birth rate: '1 in 3 Americans are underbabied'
+ Regulatory
Patient Daily | May 18, 2026

Former Rep. Paulsen on 340B: The 'program has created a healthcare system where costs are increasing for everyone'
Patient Daily | May 18, 2026

Katherine Szarama leaves acting director role at FDA's biologics center
+ Pharmaceuticals
Patient Daily | May 18, 2026

Suburban mother urges vigilance after metastatic melanoma diagnosis and treatment
+ Pharmaceuticals
Patient Daily | May 18, 2026

PhRMA CEO Stephen Ubl on 340B program: 'Patients are not benefiting'
+ Regulatory
Patient Daily | May 18, 2026

PhRMA Deputy VP Nyman on 340B: 'It’s time to ensure 340B actually helps patients'
+ Community
Patient Daily | May 18, 2026

Alliance to Save America’s 340B Program Executive Director Johnson on 340B: 'Above all, 340B must serve patients'
+ Regulatory
Patient Daily | May 15, 2026

Bliksem Health founder Rojas on 340B program: 'There is no requirement that a single dollar reach a low-income patient'

Trending
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation
+ Pharmaceuticals
Patient Daily | Aug 7, 2026

Researchers develop computer model linking brain chemistry to neural activity patterns